Insight Molecular Diagnostics Shares Outstanding 2014-2026 | IMDX
Insight Molecular Diagnostics shares outstanding from 2014 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Insight Molecular Diagnostics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 30 |
| 2024 | 13 |
| 2023 | 8 |
| 2022 | 6 |
| 2021 | 4 |
| 2020 | 3 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
|
Insight Molecular Diagnostics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 37 |
| 2026-03-31 | 35 |
| 2025-12-31 | 30 |
| 2025-09-30 | 32 |
| 2025-06-30 | 32 |
| 2025-03-31 | 26 |
| 2024-12-31 | 13 |
| 2024-09-30 | 14 |
| 2024-06-30 | 13 |
| 2024-03-31 | 8 |
| 2023-12-31 | 8 |
| 2023-09-30 | 8 |
| 2023-06-30 | 8 |
| 2023-03-31 | 6 |
| 2022-12-31 | 6 |
| 2022-09-30 | 6 |
| 2022-06-30 | 6 |
| 2022-03-31 | 5 |
| 2021-12-31 | 4 |
| 2021-09-30 | 5 |
| 2021-06-30 | 4 |
| 2021-03-31 | 4 |
| 2020-12-31 | 3 |
| 2020-09-30 | 3 |
| 2020-06-30 | 3 |
| 2020-03-31 | 3 |
| 2019-12-31 | 3 |
| 2019-09-30 | 3 |
| 2019-06-30 | 3 |
| 2019-03-31 | 2 |
| 2018-12-31 | 2 |
| 2018-09-30 | 2 |
| 2018-06-30 | 2 |
| 2018-03-31 | 2 |
| 2017-12-31 | 2 |
| 2017-09-30 | 2 |
| 2017-06-30 | 1 |
| 2017-03-31 | 1 |
| 2016-12-31 | 1 |
| 2016-09-30 | 1 |
| 2016-06-30 | 1 |
| 2016-03-31 | 1 |
| 2015-12-31 | 1 |
| 2015-09-30 | 1 |
| 2015-06-30 | 1 |
| 2015-03-31 | 1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.132B | $0.004B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |